EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitVergleichsstudie

Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy

Yingjun Zhang, Paolo Coghi, Zimo Ren, Narayan S Hosmane, Yinghuai Zhu iD

Medicinal Research Reviews · 2025-05 · 45 (3) · 867-886

DOI: 10.1002/med.22093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 17.12.2024. Verfasst von Yingjun Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sunshine Lake Pharma Co. Ltd., Dongguan, China. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Radioisotopes, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 157 Literaturangaben. Gefördert von: This research was supported by Sunshine Lake Pharma Co. Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted charged alpha‐ and beta‐particle therapies are currently being used in clinical radiation treatments as newly developed methods for either killing or controlling tumor cell growth. The alpha particles can be generated either through a nuclear decay reaction or in situ by a nuclear fission reaction such as the boron neutron capture reaction. Different strategies have been employed to improve the selectivity and delivery of radiation dose to tumor cells based on the source of the clinically used alpha particles. As a result, the side effects of the treatment can be minimized. The increasing attention and research efforts on targeted alpha‐particle therapy have been fueled by exciting results of both academic research and clinical trials. It is highly anticipated that alpha‐particle therapy will improve the efficacy of treating malignant tumors. In this overview, we compare radionuclide drug conjugates (RDC) with boron neutron capture therapy (BNCT) to present recent developments in targeted alpha‐particle therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapyRadioisotopesNeoplasmsHumansAlpha ParticlesAnimals

Stichwörter der Autor:innen

boron neutron capture therapy (BNCT)charged‐particle therapyradiation doseradiation therapyradionuclide drug conjugate

Substanzen

Radioisotopes

Autor:innen und Institutionen

  • Sunshine Lake Pharma Co. Ltd., Dongguan, China.
  • Laboratory for Drug Discovery from Natural Resources & Industrialization, School of Pharmacy, Macau University of Science and Technology, Macau, China.
  • State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
  • Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, Illinois, USA.

ORCID-Profile: Yinghuai Zhu

Förderung

  • This research was supported by Sunshine Lake Pharma Co. Ltd.

Zitieren

APA

Zhang, Y., Coghi, P., Ren, Z., Hosmane, N. S., & Zhu, Y. (2025). Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy. Medicinal Research Reviews, 45(3), 867-886. https://doi.org/10.1002/med.22093

Vancouver

Zhang Y, Coghi P, Ren Z, Hosmane NS, Zhu Y. Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy. Medicinal Research Reviews. 2025;45(3):867-886. doi:10.1002/med.22093

BibTeX
@article{Zhang2025,
  author = {Zhang, Yingjun and Coghi, Paolo and Ren, Zimo and Hosmane, Narayan S and Zhu, Yinghuai},
  title = {Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy},
  journal = {Medicinal Research Reviews},
  year = {2025},
  volume = {45},
  number = {3},
  pages = {867--886},
  doi = {10.1002/med.22093}
}
Kostenlos starten →